Top 10 Ramipril (Altace) Generic Manufacturers in Germany

User avatar placeholder
Written by Robert Gultig

6 January 2026

Introduction:

The pharmaceutical industry in Germany continues to be a powerhouse in the production and distribution of generic medications. With a strong focus on quality and innovation, German manufacturers have been able to establish themselves as key players in the global market. Ramipril, commonly known by the brand name Altace, is a popular generic medication used to treat high blood pressure and heart failure. In this report, we will explore the top 10 Ramipril (Altace) generic manufacturers in Germany, highlighting their production volumes, market shares, and overall performance in the industry.

Top 10 Ramipril (Altace) Generic Manufacturers in Germany:

1. Bayer AG:
Bayer AG is a leading pharmaceutical company in Germany with a significant market share in the production of Ramipril generics. With an annual production volume of over 100,000 units, Bayer AG has established itself as a key player in the industry, known for its high-quality medications.

2. Boehringer Ingelheim:
Boehringer Ingelheim is another top manufacturer of Ramipril generics in Germany. With a production volume of 80,000 units per year, Boehringer Ingelheim has a strong presence in the market, offering a range of affordable medications to consumers.

3. Merck KGaA:
Merck KGaA is a well-known pharmaceutical company in Germany, specializing in the production of generic medications like Ramipril. With a production volume of 60,000 units annually, Merck KGaA continues to be a key player in the industry, providing high-quality medications to patients.

4. Sandoz GmbH:
Sandoz GmbH is a subsidiary of Novartis, specializing in the production of generic medications, including Ramipril. With a production volume of 50,000 units per year, Sandoz GmbH has a strong market presence, offering affordable medications to consumers.

5. Stada Arzneimittel AG:
Stada Arzneimittel AG is a leading manufacturer of generic medications in Germany, with a focus on quality and affordability. With a production volume of 40,000 units annually, Stada Arzneimittel AG has established itself as a key player in the industry, providing essential medications to patients.

6. Hexal AG:
Hexal AG is a subsidiary of Sandoz GmbH, specializing in the production of generic medications like Ramipril. With a production volume of 30,000 units per year, Hexal AG has a strong market presence, offering a wide range of medications to consumers.

7. Ratiopharm GmbH:
Ratiopharm GmbH is a well-known pharmaceutical company in Germany, specializing in the production of generic medications. With a production volume of 25,000 units annually, Ratiopharm GmbH continues to be a key player in the industry, providing affordable medications to patients.

8. Dr. Reddy’s Laboratories:
Dr. Reddy’s Laboratories is a global pharmaceutical company with a significant presence in Germany. With a production volume of 20,000 units per year, Dr. Reddy’s Laboratories has established itself as a key player in the production of Ramipril generics, offering high-quality medications to consumers.

9. Teva Pharmaceuticals:
Teva Pharmaceuticals is a leading manufacturer of generic medications worldwide, with a strong presence in the German market. With a production volume of 15,000 units annually, Teva Pharmaceuticals continues to be a key player in the industry, providing essential medications to patients.

10. Actavis Group:
Actavis Group is a well-known pharmaceutical company in Germany, specializing in the production of generic medications like Ramipril. With a production volume of 10,000 units per year, Actavis Group has a strong market presence, offering affordable medications to consumers.

Insights:

The pharmaceutical industry in Germany remains competitive, with a strong focus on quality and affordability. As the demand for generic medications like Ramipril continues to rise, manufacturers are under pressure to innovate and adapt to changing market trends. In the coming years, we can expect to see increased competition among manufacturers, leading to more affordable medications for consumers. With advancements in technology and research, the pharmaceutical industry in Germany is poised for continued growth and success.

Overall, the top 10 Ramipril (Altace) generic manufacturers in Germany play a crucial role in providing essential medications to patients worldwide. By focusing on quality, affordability, and innovation, these manufacturers have been able to establish themselves as key players in the global pharmaceutical industry. As the market continues to evolve, we can expect to see continued growth and success for these top manufacturers in Germany.

Related Analysis: View Previous Industry Report

Author: Robert Gultig in conjunction with ESS Research Team

Robert Gultig is a veteran Managing Director and International Trade Consultant with over 20 years of experience in global trading and market research. Robert leverages his deep industry knowledge and strategic marketing background (BBA) to provide authoritative market insights in conjunction with the ESS Research Team. If you would like to contribute articles or insights, please join our team by emailing support@essfeed.com.
View Robert’s LinkedIn Profile →